{"product_id":"9783032265562","title":"Laboratory Assessments of Pediatric Leukemia","description":"\u003ch1\u003eLaboratory Assessments of Pediatric Leukemia\u003c\/h1\u003e\u003ch3\u003eWeijie Li\u003c\/h3\u003e\u003cdiv\u003e\u003cb\u003eMedical \/ Pathology\u003c\/b\u003e\u003c\/div\u003e\u003cbr\u003e\u003cdiv\u003e\n\u003cp class=\"MsoNormal\"\u003e\u003cspan style=\"mso-ascii-font-family: Aptos; mso-ascii-theme-font: minor-latin; mso-hansi-font-family: Aptos; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: 'Times New Roman'; mso-bidi-theme-font: minor-bidi;\"\u003eLeukemia is the most common childhood cancer, representing about 25% of pediatric malignancies. Survival rates have improved dramatically, especially in cases of acute lymphoblastic leukemia, where personalized, laboratory‑guided treatments now achieve cure rates near 90%. Because diagnosis, risk assessment, treatment selection, and monitoring all rely heavily on specialized laboratory testing—and because these technologies continue to evolve—there is a strong need for a comprehensive reference in this field. This book was written to fulfil that need. The text provides an up‑to‑date overview of laboratory assessments in pediatric leukemia across 21 chapters. Chapter 1 reviews disease classification, diagnosis, and treatment, highlighting the essential roles of laboratory evaluation. Chapters 2–12 cover a wide range of diagnostic and monitoring tests, from basic blood counts to advanced molecular techniques such as long‑read sequencing. Chapters 13–15 explore prognostic and predictive biomarkers in acute lymphoblastic and acute myeloid leukemia. Chapters 16–18 address laboratory testing related to CAR T‑cell therapy and stem cell transplantation. Chapter 19 discusses coagulation abnormalities associated with leukemia, while Chapters 20 and 21 describe two rare types of leukemia in children. \u003c\/span\u003e\u003c\/p\u003e\r\n\u003cp class=\"MsoNormal\"\u003e\u003cem\u003e\u003cspan style=\"mso-ascii-font-family: Aptos; mso-ascii-theme-font: minor-latin; mso-hansi-font-family: Aptos; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: 'Times New Roman'; mso-bidi-theme-font: minor-bidi;\"\u003eLaboratory Assessments of Pediatric Leukemia\u003c\/span\u003e\u003c\/em\u003e\u003cspan style=\"mso-ascii-font-family: Aptos; mso-ascii-theme-font: minor-latin; mso-hansi-font-family: Aptos; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: 'Times New Roman'; mso-bidi-theme-font: minor-bidi;\"\u003e is a comprehensive reference for pathologists, laboratory professionals, and researchers, as well as an updated resource for pediatric oncologists, hematologists, trainees, and other clinicians treating pediatric leukemias. Since most of these assessments are not exclusive to pediatric leukemia and are also relevant to adult leukemia and possibly other malignancies, this book will be beneficial for adult oncologists, hematologists, and other medical professionals or researchers.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/div\u003e\u003cdiv\u003e\n\u003cp class=\"MsoNormal\"\u003e\u003cspan lang=\"EN-US\" style=\"font-size: 11.0pt; mso-fareast-font-family: Calibri; mso-fareast-theme-font: minor-latin; mso-ansi-language: EN-US;\"\u003eDr. Weijie Li is a board-certified hematopathologist who has served as the Director of Hematopathology and Flow Cytometry for over ten years at Children's Mercy Hospital in Kansas City, United States. Through many years of practice, he has accumulated clinical expertise in diagnosing pediatric leukemias\/lymphomas, as well as other hematolymphoid diseases, and monitoring the therapeutic response of these diseases, especially the measurable residual disease (MRD) of acute leukemias. His research focuses on diagnostic and prognostic biomarkers of leukemia\/lymphoma, MRD detection, and the deregulation of signaling pathways in pediatric leukemia\/lymphoma. \u003c\/span\u003e\u003c\/p\u003e\r\n\u003cp class=\"MsoNormal\"\u003e\u003cspan lang=\"EN-US\" style=\"font-size: 11.0pt; mso-fareast-font-family: Calibri; mso-fareast-theme-font: minor-latin; mso-ansi-language: EN-US;\"\u003eDr. Li is a Professor of Pathology at the University of Missouri-Kansas City School of Medicine, and he is actively involved in teaching medical students, pathology residents, and fellows of hematopathology and hematology\/oncology. Moreover, Dr. Li serves as a reviewer for many peer-reviewed journals and has published extensively in the fields of hematopathology, hematology\/oncology, and flow cytometry. \u003c\/span\u003e\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003ctable\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublication Date: \u003c\/td\u003e\n\u003ctd\u003e12 August 2026\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublisher: \u003c\/td\u003e\n\u003ctd\u003eSpringer Nature Switzerland\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eImprint: \u003c\/td\u003e\n\u003ctd\u003eSpringer\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eISBN-13: \u003c\/td\u003e\n\u003ctd\u003e9783032265562\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFormat: \u003c\/td\u003e\n\u003ctd\u003eHardback\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePage Count: \u003c\/td\u003e\n\u003ctd\u003e514\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e","brand":"Springer Nature Switzerland","offers":[{"title":"Default Title","offer_id":47560149958796,"sku":"9783032265562","price":152.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0710\/9545\/1788\/files\/9783032265562_c6f768f3-2fb2-4d4b-856e-04cc621debb3.jpg?v=1781089110","url":"https:\/\/fh90cf-fv.myshopify.com\/products\/9783032265562","provider":"Late Knight Books and Services, LLC","version":"1.0","type":"link"}